Pittenger & Anderson Inc. Sells 1,089 Shares of CME Group Inc. (NASDAQ:CME)

Pittenger & Anderson Inc. trimmed its holdings in CME Group Inc. (NASDAQ:CME) by 1.6% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 65,580 shares of the financial services provider’s stock after selling 1,089 shares during the period. Pittenger & Anderson Inc.’s holdings in CME Group were worth $14,470,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Harbor Capital Advisors Inc. boosted its holdings in CME Group by 0.6% in the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after purchasing an additional 45 shares in the last quarter. CVA Family Office LLC lifted its position in shares of CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after buying an additional 46 shares during the last quarter. Lester Murray Antman dba SimplyRich boosted its stake in shares of CME Group by 0.7% during the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after acquiring an additional 50 shares in the last quarter. Essex LLC increased its holdings in shares of CME Group by 3.3% during the 1st quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock valued at $355,000 after acquiring an additional 52 shares during the last quarter. Finally, Quent Capital LLC increased its holdings in shares of CME Group by 10.2% during the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after acquiring an additional 55 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a research report on Tuesday, October 8th. JPMorgan Chase & Co. upped their price objective on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 target price on shares of CME Group in a report on Thursday, October 24th. TD Cowen started coverage on shares of CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 price target for the company. Finally, The Goldman Sachs Group lifted their price objective on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus target price of $222.73.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other CME Group news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now directly owns 25,067 shares in the company, valued at $5,587,935.64. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,621 shares of company stock worth $3,441,063. Company insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ CME opened at $223.08 on Tuesday. The firm has a market capitalization of $80.33 billion, a price-to-earnings ratio of 23.46, a PEG ratio of 5.62 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36. The business has a fifty day simple moving average of $220.98 and a 200 day simple moving average of $209.58. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the company posted $2.25 EPS. The business’s revenue was up 18.4% on a year-over-year basis. Sell-side analysts expect that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.